Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Refining the indications of implantable cardioverter defibrillator in patients with left ventricular dysfunction.

González-Torrecilla E, Arenal A, Atienza F, Datino T, Eidelman G, Miracle A, Hernández J, Avila P, Fernández-Avilés F.

Rev Recent Clin Trials. 2012 Aug;7(3):197-203. Review.

PMID:
22540903
2.

Predictors of appropriate implantable cardioverter-defibrillator therapy during long-term follow-up of patients with coronary artery disease.

Blumer J, Wolber T, Hellermann J, Holzmeister J, Binggeli C, Duru F, Brunckhorst C.

Int Heart J. 2009 May;50(3):313-21.

3.

Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.

Lelakowski J, Piekarz J, Rydlewska A, Majewski J, Senderek T, Ząbek A, Małecka B.

Kardiol Pol. 2012;70(11):1099-110.

4.

Implantable cardioverter defibrillator therapy for patients with less severe left ventricular dysfunction.

Exner DV.

Curr Opin Cardiol. 2009 Jan;24(1):61-7. doi: 10.1097/HCO.0b013e32831c4cc5. Review.

PMID:
19077818
5.

Kidney dysfunction and deterioration of ejection fraction pose independent risk factors for mortality in implantable cardioverter-defibrillator recipients for primary prevention.

Kreuz J, Horlbeck F, Schrickel J, Linhart M, Fimmers R, Mellert F, Nickenig G, Schwab JO.

Clin Cardiol. 2012 Sep;35(9):575-9. doi: 10.1002/clc.22018. Epub 2012 Jun 15.

7.

Current Indications for Implantable Cardioverter Defibrillators in Non-Ischemic Cardiomyopathies and Channelopathies.

González-Torrecilla E, Arenal A, Atienza F, Datino T, Bravo L, Ruiz P, Ávila P, Fernández-Avilés F.

Rev Recent Clin Trials. 2015;10(2):111-27. Review.

PMID:
25845953
8.

Long-term clinical outcome in patients with severe left ventricular dysfunction and an implantable cardioverter-defibrillator after ventricular tachyarrhythmias.

Pelicano N, Oliveira M, Da Silva N, Antunes E, Santos S, Conceição JM, Roquette J, Quininha J.

Rev Port Cardiol. 2005 Apr;24(4):487-98. English, Portuguese.

PMID:
15977773
11.

Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study.

Connolly SJ, Hallstrom AP, Cappato R, Schron EB, Kuck KH, Zipes DP, Greene HL, Boczor S, Domanski M, Follmann D, Gent M, Roberts RS.

Eur Heart J. 2000 Dec;21(24):2071-8.

PMID:
11102258
12.

Time dependence of defibrillator benefit after coronary revascularization in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II.

Goldenberg I, Moss AJ, McNitt S, Zareba W, Hall WJ, Andrews ML, Wilber DJ, Klein HU; MADIT-II Investigators.

J Am Coll Cardiol. 2006 May 2;47(9):1811-7. Epub 2006 Apr 17.

13.

[Sudden cardiac death in patients with left ventricular dysfunction from ischemic heart disease: role of the implantable defibrillator. Evidence, guidelines and good clinical judgment].

Serdoz LV, Fabris E, Lutman C, Merlo M, Zecchin M, Sinagra G.

G Ital Cardiol (Rome). 2012 Sep;13(9):592-601. doi: 10.1714/1133.12487. Review. Italian.

PMID:
22825344
14.

Implantable cardioverter defibrillator therapy in postinfarction patients.

Zareba W.

Curr Opin Cardiol. 2004 Nov;19(6):619-24. Review.

PMID:
15502509
15.

Implantable cardioverter-defibrillator efficacy in patients with heart failure and left ventricular dysfunction (from the MADIT II population).

Zareba W, Piotrowicz K, McNitt S, Moss AJ; MADIT II Investigators.

Am J Cardiol. 2005 Jun 15;95(12):1487-91.

PMID:
15950580
16.

Implantable defibrillators for secondary prevention of sudden cardiac death in cardiac surgery patients with perioperative ventricular arrhythmias.

Nageh MF, Kim JJ, Chen LH, Yao JF.

J Am Heart Assoc. 2014 Aug 21;3(4). pii: e000686. doi: 10.1161/JAHA.113.000686.

17.

Prognostic role of post-infarction C-reactive protein in patients undergoing implantation of cardioverter-defibrillators: design of the C-reactive protein Assessment after Myocardial Infarction to GUide Implantation of DEfibrillator (CAMI GUIDE) study.

Bellocci F, Biasucci LM, Gensini GF, Padeletti L, Raviele A, Santini M, Giubilato G, Landolina M, Biondi-Zoccai G, Raciti G, Sassara M, Castro A, Kheir A, Crea F.

J Cardiovasc Med (Hagerstown). 2007 Apr;8(4):293-9.

PMID:
17413310
18.
20.

Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy?

Ellenbogen KA, Levine JH, Berger RD, Daubert JP, Winters SL, Greenstein E, Shalaby A, Schaechter A, Subacius H, Kadish A; Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators.

Circulation. 2006 Feb 14;113(6):776-82. Epub 2006 Feb 6.

Supplemental Content

Support Center